Westham Competitors and Similar CompaniesClear all

Alnylam Pharmaceuticals's competitors and similar companies include Merus, Olainfarm and Aerie Pharmaceuticals.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Olainfarm
Olainfarm
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
Founding Date
Founding Date
2002
Founding Date
2003
Founding Date
1972
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Utrecht, NL HQ
Cambridge, US
Locations
Olaine, LV HQ
Locations
Irvine, US HQ
Dublin, IE
千代田区, JP
Henley On Thames, GB
Bedminster, US
Durham, US
Employees
Employees
1,32324% increase
Employees
1725% increase
Employees
2,191
Employees
3808% increase
Valuation ($)
Valuation ($)
18.8 b
Valuation ($)
2.5 b
Valuation ($)
150.2 m
Valuation ($)
722.2 m
Twitter followers
Twitter followers
16.3 k
Twitter followers
N/A
Twitter followers
716
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
86.96%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
$41.6m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
$194.1m (FY, 2021)
Cost of goods
Cost of goods
$268.2m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$26.8m (FY, 2021)
Gross profit
Gross profit
$1.6b (FY, 2023)
Gross profit
$41.6m (FY, 2022)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($440.2m) (FY, 2023)
Net income
($131.2m) (FY, 2022)
Net income
N/A
Net income
($74.8m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 1.5b
Total funding raised
$ 149.3m
Total funding raised
N/A
Total funding raised
$ 388.6m
For sources of this data, please see the company profile

View Company Profiles

Merus
HQ
Utrecht, NL
Employees
172↑ 5% increase

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company
Olainfarm
HQ
Olaine, LV
Employees
2,191

Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.

View company
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

View company